VERTEX PHARMACEUTICALS INC / MA Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 114.37 | 181 | 20,701 | 106,011 | 106.2 K to 106 K (-0.17 %) |
| May 17 2017 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP, CFO & COO | Sell | S | 114.92 | 294 | 33,786 | 126,238 | 126.5 K to 126.2 K (-0.23 %) |
| May 17 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 114.37 | 116 | 13,267 | 99,335 | 99.5 K to 99.3 K (-0.12 %) |
| May 17 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 114.64 | 271 | 31,067 | 20,071 | 20.3 K to 20.1 K (-1.33 %) |
| May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 91.05 | 8,979 | 817,538 | 19,756 | |
| May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 121.05 | 8,979 | 1,086,908 | 122,511 | 131.5 K to 122.5 K (-6.83 %) |
| May 04 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 91.05 | 8,979 | 817,538 | 131,490 | 122.5 K to 131.5 K (+7.33 %) |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 63.14 | 7,500 | 473,550 | 0 | |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 120.00 | 7,500 | 900,000 | 106,011 | 113.5 K to 106 K (-6.61 %) |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 63.14 | 7,500 | 473,550 | 113,511 | 106 K to 113.5 K (+7.07 %) |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 28,320 | 1,277,515 | 0 | |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 119.50 | 28,320 | 3,384,240 | 131,247 | 159.6 K to 131.2 K (-17.75 %) |
| May 02 2017 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 28,320 | 1,277,515 | 159,567 | 131.2 K to 159.6 K (+21.58 %) |